Indies Pharma Jamaica Limited reported earnings results for the first quarter ended January 31, 2023. For the first quarter, the company reported sales was JMD 255.64 million compared to JMD 212.3 million a year ago. Net income was JMD 59.03 million compared to JMD 50.22 million a year ago.

Basic earnings per share from continuing operations was JMD 0.04 compared to JMD 0.04 a year ago.